Skin Treatment (Pharmacies) - Egypt

  • Egypt
  • Revenue in the Skin Treatment market is projected to reach US$133.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 10.98%, resulting in a market volume of US$224.60m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.17 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Egypt is experiencing steady growth due to increasing customer preferences for skincare products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Egypt are increasingly becoming conscious about their skincare and are seeking effective solutions for various skin conditions. This has led to a growing demand for skin treatment products in pharmacies. Customers are looking for products that are dermatologically tested, contain natural ingredients, and provide visible results. They also prefer products that are affordable and easily accessible in their local pharmacies.

Trends in the market:
One of the major trends in the Skin Treatment (Pharmacies) market in Egypt is the rising popularity of organic and natural skincare products. Customers are becoming more aware of the potential harmful effects of synthetic chemicals and are opting for products that are free from harsh ingredients. This trend is driving the demand for natural and organic skin treatment products in pharmacies. Another trend in the market is the increasing use of technology in skincare. Customers are looking for innovative products that incorporate advanced technologies such as LED therapy, microcurrents, and ultrasonic technology. These products offer targeted treatment and are seen as more effective in addressing specific skin concerns. Pharmacies are responding to this trend by stocking a wide range of technologically advanced skin treatment products.

Local special circumstances:
Egypt has a large population, which provides a significant customer base for the Skin Treatment (Pharmacies) market. The country also has a strong pharmaceutical industry, with a wide network of pharmacies across the country. This makes it convenient for customers to access skincare products in their local pharmacies. In addition, Egypt has a rich history of natural remedies and traditional skincare practices. This has influenced customer preferences for natural and herbal skincare products. Many local brands in Egypt are capitalizing on this trend by offering products that incorporate traditional ingredients and formulas.

Underlying macroeconomic factors:
The growing economy of Egypt is contributing to the development of the Skin Treatment (Pharmacies) market. As disposable incomes increase, customers have more purchasing power to invest in skincare products. The rising middle class in Egypt is particularly driving the demand for premium and high-end skin treatment products. Furthermore, the increasing urbanization in Egypt is creating a greater awareness about skincare and grooming. Urban dwellers are more exposed to global beauty trends and are willing to invest in skincare products to maintain a healthy and youthful appearance. This is fueling the growth of the Skin Treatment (Pharmacies) market in urban areas. In conclusion, the Skin Treatment (Pharmacies) market in Egypt is growing due to customer preferences for skincare products, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for natural and organic products, as well as technologically advanced skincare, is driving the market forward. The large population, strong pharmaceutical industry, and increasing disposable incomes are contributing to the growth of the market in Egypt.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)